Since its founding as a family business in 1920, Endo has evolved into a generics and specialty branded pharmaceutical company whose products help millions of patients lead healthier lives. We are deeply concerned about the opioid abuse crisis, a public health challenge unprecedented in scope, severity and complexity.  We believe this crisis can only be solved through intensive collaboration among the multiple stakeholders involved in our healthcare system. 

The U.S. Food and Drug Administration (FDA) has worked to balance access to pain care medications for appropriate patients while aggressively mitigating the risks of opioid abuse.  Endo supports these efforts and has taken parallel actions.  Since our new Executive Leadership Team began working together in September 2016, Endo voluntarily stopped promoting opioid products to healthcare professionals and eliminated the Company’s entire pain product salesforce.  Endo also voluntarily withdrew Opana® ER from the market, discontinued the research and development of new opioid products and implemented additional anti-diversion measures, including product serialization aimed at thwarting counterfeiting and theft to protect patient safety.

While we are proud of Endo’s actions, neither we nor any other single actor can solve the opioid abuse crisis.  Instead, any solution must be multifaceted and consider not only the product supply chain, but also individual risk factors and other factors affecting utilization decisions, together with scientific, legislative and regulatory measures, training, treatment and education.  Criminal trafficking of opioids (including heroin and fentanyl), illegal Internet sales and importation must also be addressed.  Finally, the legitimate access needs of the millions of patients suffering from acute or chronic pain who rely on opioid medications must be considered.  We remain committed to working collaboratively and proactively on a comprehensive solution to the opioid abuse crisis and to continuing Endo’s longstanding mission of improving patients’ lives.